Ameritas Investment Partners Inc. Reduces Stake in HealthEquity, Inc. (NASDAQ:HQY)

Ameritas Investment Partners Inc. lessened its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 1.7% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,302 shares of the company’s stock after selling 598 shares during the quarter. Ameritas Investment Partners Inc.’s holdings in HealthEquity were worth $2,957,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Cape Investment Advisory Inc. bought a new position in shares of HealthEquity in the fourth quarter worth $27,000. Rise Advisors LLC bought a new stake in HealthEquity during the first quarter valued at $28,000. International Assets Investment Management LLC purchased a new position in HealthEquity during the second quarter worth about $35,000. YHB Investment Advisors Inc. bought a new position in HealthEquity in the 1st quarter worth about $40,000. Finally, Fidelis Capital Partners LLC bought a new position in HealthEquity in the 1st quarter worth about $42,000. 99.55% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on HQY shares. KeyCorp boosted their price objective on HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a report on Wednesday, June 5th. Royal Bank of Canada reiterated an “outperform” rating and set a $92.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Barrington Research reissued an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a report on Friday. Raymond James lifted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Friday, June 7th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $103.83.

HealthEquity Price Performance

HQY stock opened at $79.53 on Friday. The firm has a market cap of $6.92 billion, a P/E ratio of 86.45, a P/E/G ratio of 1.19 and a beta of 0.52. The firm’s fifty day moving average is $76.17 and its 200 day moving average is $79.32. HealthEquity, Inc. has a 52 week low of $61.81 and a 52 week high of $88.26. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

Insider Buying and Selling at HealthEquity

In other news, Vice Chairman Stephen Neeleman sold 35,000 shares of HealthEquity stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the transaction, the insider now owns 89,769 shares in the company, valued at $7,168,952.34. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the completion of the sale, the insider now owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Jon Kessler sold 32,326 shares of HealthEquity stock in a transaction on Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the transaction, the chief executive officer now directly owns 232,176 shares in the company, valued at $19,231,138.08. The disclosure for this sale can be found here. Insiders sold a total of 75,031 shares of company stock worth $6,103,625 over the last three months. Company insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.